Quick Takeaways
- BIOTECHNOLOGY VALUE FUND L P filed SCHEDULE 13G/A for Ikena Oncology, Inc. Common Stock, par value $0.001 per share (IKNA).
- Disclosed ownership: 8.3%.
- Date of event: 31 Dec 2024.
Quoteable Key Fact
"BIOTECHNOLOGY VALUE FUND L P disclosed 8.3% ownership in Ikena Oncology, Inc. Common Stock, par value $0.001 per share (IKNA) on 31 Dec 2024."
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original Filing| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| BIOTECHNOLOGY VALUE FUND L P | 4.3% | 2,066,854 | 0 | 2,066,854 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF I GP LLC | 4.3% | 2,066,854 | 0 | 2,066,854 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BIOTECHNOLOGY VALUE FUND II LP | 3.5% | 1,669,108 | 0 | 1,669,108 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF II GP LLC | 3.5% | 1,669,108 | 0 | 1,669,108 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| Biotechnology Value Trading Fund OS LP | 0.4% | 208,765 | 0 | 208,765 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF Partners OS Ltd. | 0.4% | 208,765 | 0 | 208,765 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF GP HOLDINGS LLC | 7.7% | 3,735,962 | 0 | 3,735,962 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF PARTNERS L P/IL | 8.3% | 4,006,564 | 0 | 4,006,564 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF INC/IL | 8.3% | 4,006,564 | 0 | 4,006,564 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| LAMPERT MARK N | 8.3% | 4,006,564 | 0 | 4,006,564 | /s/ Mark N. Lampert | Mark N. Lampert |